| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2012: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Research Abstract |
In this study, we attempted to develop a novel type of nanobubble anticancer agent for treating metastatic liver tumor derived from pancreatic cancer, and to evaluate the effectiveness. We prepared the mice which were received transplantation of tumor cell line, and performed high frequency ultrasonography to the mice using the agent and evaluated the enhancement of the liver in early stage of the transplantation. The enhancement effect was certified and the effect was similar to a microbubble agent used in clinical (SonazoidR).
|
